• Zenas BioPharma granted 74,900 restricted stock units to newly hired employees on October 15, 2026.
• The awards fall under the 2026 Inducement Plan.
• Vesting occurs in 25% installments on October 15, 2027, October 15, 2028, October 15, 2029, and October 15, 2030.
• Each installment requires continued employment through the applicable vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610161615PRIMZONEFULLFEED9847480) on October 16, 2026, and is solely responsible for the information contained therein.